Fidaxomicin in Clostridium difficile infection: Added benefit not proven
The antibiotic fidaxomicin (trade name: Dificlir) has been approved in Germany since December 2011 for the treatment of adults who have diarrhoea caused by Clostridium difficile. In an early benefit assessment pursuant to ...
Jul 2, 2013
0
0